Your Article Summary
Boston Scientifics Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan
Boston Scientific, 11/10/09
Boston Scientific Corporation announced the launch of its COGNIS cardiac resynchronization therapy defibrillator and TELIGEN implantable cardioverter defibrillator in Japan. These devices were approved by the Japanese Ministry of Health, Labor and Welfare in August and received reimbursement approval in September. COGNIS and TELIGEN are the result of a multi–year research and development effort to provide physicians enhanced clinical options for their patients.
Today in Medical Devices/Products...keeping you current
Receive free subspecialty "5-minute updates" via email
Chugai Revises Corporate Advertisement for First Time in Four Years
Chugai Pharmaceutical Co., 11/25/09
Huntington Hill Installs Toshiba Aquilion Premium CT
Imaging Economics, 11/25/09
Baytubes carbon nanotubes in marine coatings help reduce frictional resistance
BayNews International, 11/24/09
Article Search
Sponsor


See Latest Articles


